RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does RaySearch Laboratories AB (publ) (RAY-B) operate in?
RaySearch Laboratories AB (publ) belongs to the Healthcare sector and operates in the Health Information Services industry.
What is RaySearch Laboratories AB (publ) (RAY-B) current stock price?
As of the latest data, RaySearch Laboratories AB (publ) stock price is SEK 192.70, with a previous close of SEK 191.90. RaySearch Laboratories AB (publ) gained SEK 0.80 in the last trading session, representing a 0.42% increase.
What is RaySearch Laboratories AB (publ) (RAY-B) current market capitalization?
RaySearch Laboratories AB (publ) market cap is approximately 5.74 billion.
What is RaySearch Laboratories AB (publ) (RAY-B) Earnings Per Share (EPS)?
The trailing EPS is SEK 6.24, and the forward EPS is SEK 8.68.
What is RaySearch Laboratories AB (publ) (RAY-B) Price-to-Earnings (P/E) ratio?
RaySearch Laboratories AB (publ) current P/E ratio is 30.88, with a forward P/E of 22.2.
What is RaySearch Laboratories AB (publ) (RAY-B) EBITDA?
RaySearch Laboratories AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 91.60 million.
Does RaySearch Laboratories AB (publ) (RAY-B) pay dividends?
Yes. RaySearch Laboratories AB (publ) pays annual dividends with an annualized yield of 2.08% and an estimated annual payout of SEK 4.00 per share.
When is the next ex-dividend date for RaySearch Laboratories AB (publ) (RAY-B)?
The next ex-dividend date is scheduled for May 08, 2027.
How did RaySearch Laboratories AB (publ) (RAY-B) perform in its most recent earnings report?
In the last report (June 30, 2026), RaySearch Laboratories AB (publ) posted an EPS surprise of -5% and a revenue surprise of 0.11%.
When is RaySearch Laboratories AB (publ) (RAY-B) next earnings report?
RaySearch Laboratories AB (publ) is expected to release its next earnings report on September 30, 2026.
What is RaySearch Laboratories AB (publ) (RAY-B) beta (volatility) score?
RaySearch Laboratories AB (publ) has a beta of 0.920, meaning its volatility is roughly in line with the market.
